Movano Health receives Nasdaq deficiency notice for late Q2 10-Q; awaits Panel decision on stay

Corvex, Inc.

Nasdaq notice received Aug 21, 2025 for failure to file Form 10-Q due Aug 14, 2025.
Hearing held Aug 19, 2025; compliance plan submitted covering filing and minimum bid price rules.
New auditor RBSM LLP engaged Aug 13, 2025 as part of compliance plan.
No assurance Panel will grant stay or that Movano can regain compliance and maintain listing.
Stock ticker MOVE trades on Nasdaq Capital Market; risk of suspension if Panel denies request.

item 3.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.